Healthcare & Life Sciences
Ashvattha Therapeutics
United States
acquiredacquired
acquired
Stage
1
Investors
About
Ashvattha Therapeutics was a biopharmaceutical company focused on developing therapeutic drugs. It was part of Catalio Capital's life sciences portfolio and exited investment in 2019.
Explore Ashvattha Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.